US FDA Shows Support For Generic Drug User Fee Goals Amid Cutbacks

 
• By Michael McCaughan
  
Arrows hitting targets
FDA's Office of Generic Drugs understands the importance of hitting the mark on user fee goal dates. (Shutterstock)

More from Regulation

More from Products